// company-profile

PharmaCyte Biotech, Inc. Insider Trading

PMCB

Every SEC Form 4 insider trading filing for PharmaCyte Biotech, Inc. (PMCB) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.

ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.NVFilings25Insiders6
// api This PharmaCyte Biotech, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
curl "https://api.form4api.com/v1/transactions?ticker=PMCB" -H "X-Api-Key: YOUR_API_KEY"

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for PMCB in the last 90 days.

Institutional Ownership

Top 13F-HR holders of PharmaCyte Biotech, Inc. as of 2026-06-30

— stable
Total reported AUM
$32,738
QoQ change
Reporting period
2026-06-30
#1
EQUITEC PROPRIETARY MARKETS, LLC
CIK 1143261
$17,115
22K shares
#2
COMMONWEALTH EQUITY SERVICES, LLC
CIK 312272
$15,600
20K shares
#3
Sachetta, LLC
CIK 2010574
$11
14 shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Mar 31, 2026WEINSTEIN ROBERTPMCB
J
0
Mar 31, 2026SCHECHTER JONATHANPMCB
J
0
Mar 31, 2026Abecassis Michael MPMCB
J
0
Mar 31, 2026WALKER WAYNE REMELLPMCB
J
0
Jan 7, 2026SCHECHTER JONATHANPMCB
Purchase
20,000$0.84$17K

29 more transactions hidden

Free account · No credit card required

Building something? Get API access →